Burden, Temporal Trends, and Projections of Hodgkin Lymphoma in South Asia, 1990–2040: A Systematic Analysis of the Global Burden of Disease Study 2023

Cancer is a group of diseases where cells grow out of control, but not all cancers behave the same way. Some are aggressive and hard to treat, while others, though serious, can be cured if caught early and managed with the right care. One such disease is Hodgkin lymphoma, a type of cancer that starts in the immune system. It is known for having a distinct pattern: it often strikes young adults in their twenties and thirties, and then again in older adults. While it is rare compared to other cancers, it is one of the most treatable forms of the disease, especially in wealthy nations where advanced medicines and radiation are readily available. However, in many parts of the world, the story is different. Access to diagnosis and treatment varies wildly, meaning that a disease that is often curable can still be fatal for many people. Understanding how this disease affects different populations, and whether those effects are getting better or worse over time, is crucial for doctors and policymakers who want to save lives.

A team of researchers recently looked at the big picture of Hodgkin lymphoma across South Asia, a region that includes India, Pakistan, Bangladesh, Nepal, and Bhutan. They wanted to know how many people were getting sick, how many were dying, and how the situation had changed over the last thirty years. To do this, they did not conduct new experiments or interview patients directly. Instead, they gathered and analyzed a massive collection of existing data from a global health project that tracks diseases everywhere. They looked at numbers from 1990 all the way to 2023, and then used computer models to guess what might happen by the year 2040. Their goal was to see if the region was moving in the right direction and to spot where help was still needed most.

The results show a story of two very different realities. On the one hand, the overall risk of dying from Hodgkin lymphoma in South Asia has dropped significantly. When the researchers adjusted the numbers to account for the fact that populations are getting older and larger, they found that the rate of new cases, the rate of deaths, and the overall burden of the disease all went down between 1990 and 2023. In countries like Bangladesh, Nepal, and India, these improvements were quite strong. The rate of death per person fell by more than half in some of these places. This suggests that medical care is getting better, that people are being diagnosed earlier, and that more patients are surviving the disease.

However, the story changes when you look at the total number of people affected. Even though the risk for any single individual has gone down, the total number of new cases and the total number of people living with the disease have actually gone up across the region. This happened because the population of South Asia has grown so large and is aging, which means there are simply more people at risk. It is similar to how a town might see fewer accidents per driver even as the total number of accidents rises because there are now twice as many cars on the road. In this case, the medical progress is real, but it is being partially hidden by the sheer size of the population.

The most striking finding of the study is how uneven the progress is across the region. While Bangladesh, Nepal, and India have seen steady improvements, Pakistan has been left behind. In Pakistan, the rate of new cases, the number of deaths, and the overall burden of the disease remained the highest in the entire region. The researchers found that while other countries were seeing their death rates drop quickly, Pakistan's progress was much slower. By 2023, the number of people dying from the disease in Pakistan was disproportionately high compared to its neighbors. The data suggests that people in Pakistan are still presenting with the disease at later stages, likely because they cannot access timely medical care or diagnosis. This gap means that while the rest of the region is moving toward a future where the disease is less deadly, Pakistan is still struggling with a much heavier burden.

Looking ahead, the researchers used statistical models to project what will happen over the next two decades. They predict that the trend of falling death rates will continue through 2040, driven largely by improvements in India and Bangladesh. The models suggest that the number of deaths and the overall suffering caused by the disease will keep going down. However, the projection also indicates that Pakistan will likely continue to carry a heavier burden than the rest of the region. The models show that while the death rate in Pakistan will eventually drop, it will remain higher than in neighboring countries for the foreseeable future.

The study also highlighted who is most affected. Men are more likely to get the disease and more likely to die from it than women. The disease also tends to hit two specific age groups hardest: young adults and the elderly. The researchers noted that older patients often have a harder time surviving, partly because they may not tolerate the strong treatments as well as younger people. This suggests that as the population ages, the way doctors treat older patients will become even more important.

Despite the encouraging trend of falling death rates, the researchers point out that the job is not done. The fact that the total number of cases is rising means that health systems need to be ready to treat more people than ever before. They emphasize that the biggest challenge is not just having the medicine, but making sure it reaches everyone, especially in places like Pakistan where the burden is highest. The study concludes that to truly reduce the impact of this disease, South Asia needs to strengthen its ability to track cancer cases, find them early, and ensure that every patient, regardless of where they live, can get the treatment they need. The path forward is clear, but it requires a focused effort to close the gap between the countries that are succeeding and the one that is still struggling.